PRESL, J., Petra OVESNÁ, Z. NOVOTNY, P. VLASAK, J. BOUDA, J. KOSTUN, O. TOPOLCAN, R. KUCERA, Markéta BEDNAŘÍKOVÁ and Vít WEINBERGER. Importance of Preoperative Knowledge of the Biomarker HE4 in Early-stage Endometrial Cancer Regarding Surgical Management. Anticancer Research. Athens: The International Institute of Anticancer Research, 2017, vol. 37, No 5, p. 2697-2702. ISSN 0250-7005. Available from: https://dx.doi.org/10.21873/anticanres.11619.
Other formats:   BibTeX LaTeX RIS
Basic information
Original name Importance of Preoperative Knowledge of the Biomarker HE4 in Early-stage Endometrial Cancer Regarding Surgical Management
Authors PRESL, J. (203 Czech Republic), Petra OVESNÁ (203 Czech Republic, guarantor, belonging to the institution), Z. NOVOTNY (203 Czech Republic), P. VLASAK (203 Czech Republic), J. BOUDA (203 Czech Republic), J. KOSTUN (203 Czech Republic), O. TOPOLCAN (203 Czech Republic), R. KUCERA (203 Czech Republic), Markéta BEDNAŘÍKOVÁ (203 Czech Republic, belonging to the institution) and Vít WEINBERGER (203 Czech Republic, belonging to the institution).
Edition Anticancer Research, Athens, The International Institute of Anticancer Research, 2017, 0250-7005.
Other information
Original language English
Type of outcome Article in a journal
Field of Study 30204 Oncology
Country of publisher Greece
Confidentiality degree is not subject to a state or trade secret
Impact factor Impact factor: 1.865
RIV identification code RIV/00216224:14110/17:00098150
Organization unit Faculty of Medicine
Doi http://dx.doi.org/10.21873/anticanres.11619
UT WoS 000402173300069
Keywords in English CA125; HE4; endometrial cancer; preoperative staging
Tags EL OK
Tags International impact, Reviewed
Changed by Changed by: Soňa Böhmová, učo 232884. Changed: 20/3/2018 17:44.
Abstract
Aim: To analyze the utility of HE4 assessment in preoperative management of patients with early-stage endometrial cancer for stratification into low-risk and high-risk groups. Patients and Methods: The following data were prospectively collected from patients operated for endometrial cancer from 05/2012 till 9/2016; age, HE4, CA125, expert ultrasound examination of the pelvis, histotype, grade, FIGO stage. Results: In total, 124 patients were enrolled. A cut-off of >= 113 pmol/l HE4 demonstrated 40.3% sensitivity and 83.9% specificity for detection of high-risk patients. Correlations of HE4 with age (p<0.001), depth of myometrial invasion (p=0.001), clinical stage of the disease according to ultrasound - T1a vs. T1b (63.6 pmol/l vs. 110.6 pmol/l, p<0.001) were found. However, no correlation of HE4 with lymph node invasion (p=0.07) and tumor grade (p=0.212) was identified. Conclusion: HE4 levels correspond to clinical and FIGO stage of the disease. The sensitivity and specificity does not reach the transvaginal ultrasound results in preoperative assessment of the extent of the disease. Combination of HE4 with ultrasound does not improve the stratification of patients into low-risk and high-risk groups. Preoperative assessment of HE4 is useful providing no imaging method is available.
PrintDisplayed: 16/7/2024 00:29